RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 The PARTNER Trial: A New Paradigm for Treating Valvular Heart Disease
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 15
SP 30
OP 31
DO 10.1177/155989771115018
UL http://mdc.sagepub.com/content/11/15/30.abstract
AB The Placement of AoRTic TraNscathetER Valve [PARTNER] Trial showed for the first time that transcatheter aortic valve implantation (TAVI), when used in inoperable patients with severe symptomatic aortic stenosis, is life-saving and the best therapeutic option compared with standard medical therapy. In high-risk (but operable) patients, no outcome differences were noted between TAVI and surgical replacement of the aortic valve.